Share This Article

Facebook LinkedIn
Twitter Reddit
Print Email
Pinterest Gmail
Yahoo
Money Morning
×
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • Angel Investing
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
  • Retire
    • Income Investing Guide
    • Retirement Articles
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
Login My Member Benefits Archives Research Your Team About Us FAQ
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • Angel Investing
    ×
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
    ×
  • Retire
    • Income Investing Guide
    • Retirement Articles
    ×
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    ×
  • Subscribe
Enter stock ticker or keyword
×
5 Ways to Beat the Fed (and Crush Inflation)

Email this Article

Send with mail | ahoo instead.
Required Needs to be a valid email
Required Needs to be a valid email
The Top Penny Stock to Buy Today for 549% Profit Potential
https://moneymorning.com/?p=1137700
Required Please enter the correct value.
Twitter
Stocks: CVSI, CWBHF

The Top Penny Stock to Buy Today for 549% Profit Potential

By Mike Stenger, Associate Editor, Money Morning • April 6, 2020

View Comments

Start the conversation

Comment on This Story Click here to cancel reply.

Or to contact Money Morning Customer Service, click here.

Your email address will not be published. Required fields are marked *

Some HTML is OK

No one knows how long the coronavirus pandemic will last. That's sent markets into a tailspin. The Dow Jones Industrial Average hit a three-year low of 18,500 in the 2020 market crash, down from all-time highs above 29,000 to start the year.

It's been a wild ride. But we do know one thing: Our top penny stock to buy today has 549% profit potential.

The pandemic will end at some point. While it's slowed the economy, it's not going to permanently halt major growth industries that have been building for years.

The legal cannabis industry is set to grow 470% between now and 2027, from $10 billion to $57 billion. Within that, you have the incredibly robust CBD industry growing to $22 billion by 2022 - that's from just $500 million in 2018.

And one of the best ways to cash in on this upside is with penny stocks.

Warning: Trillions of dollars of Fed "stimulus" can't stop COVID-19 from devastating markets and economies - but it can sure make things worse. Find out what's next in this just-released report...

You see, penny stocks trade for under $5 a share, which means they can make huge percentage leaps on broad market moves. When the CBD industry skyrockets, this penny stock will launch even further.

Here's why CBD penny stocks make a lot of sense right now - and how this one offers upside potential of 500%...

CBD Penny Stocks Are Going to Pop

Cannabis had some setbacks in the last year, but another breakout is brewing.

The ETFMG Alternative Harvest ETF (NYSEArca: MJ) has lost more than 70% since 2019. Don't let that stop you. Last year was typical for an industry as young as marijuana. The cannabis industry has still been shuffling winners and losers as the companies discover what drives demand and what doesn't.

CBD might be a cannabis industry leader in terms of solidifying future demand. It more than doubled revenue from 2016 to 2018.

The compound is getting attention for its healing properties, both for body aches and depressive symptoms. Professional athletes have even advocated it for recovery purposes: Golfer Bubba Watson, ex-Pro Bowl Tight End Rob Gronkowski, and ex-MLB Pitcher David Wells, to name a few.

Now, one of the only things standing in the way of CBD is the U.S. Food and Drug Administration (FDA).

Though CBD has shown effectiveness against a variety of ailments, the FDA is still shy about officially approving it. It's even filed class actions against some CBD companies like Charlotte's Web Holdings Inc. (OTCMKTS: CWBHF) and CV Sciences Inc. (OTCMKTS: CVSI) for "illegal CBD products" because it is not an "approved dietary ingredient in foods and supplements."

The FDA maintains that it was "first investigated as a drug," which is why the organization is taking more time to examine CBD at the start of 2020.

This wave of scrutiny, of course, was inevitable for the CBD industry. Some will face it; others might slip by.

But in time, CBD will get approved. Why?

The dam is already broken. CBD food and supplements are in stores everywhere. People love them. They are even essential medical products during the coronavirus lockdown.

In fact, this CBD penny stock is already a household name. And it just released an eye-popping Q1 earnings report...

The Best Penny Stock to Buy Today

Join the conversation. Click here to jump to comments…

Mike StengerMike Stenger

About the Author

Browse Mike's articles | View Mike's research services

Mike Stenger, Associate Editor forĀ Money MorningĀ at Money Map Press,Ā graduated from the Perdue School of Business at Salisbury University. He has combined his degree in Economics with an interest in emerging technologies by finding where tech and finance overlap. Today, he studies the cybersecurity sector, AI, streaming, and the Cloud.

… Read full bio

Login
guest
guest
1 Comment
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Bernard Saintilien
Bernard Saintilien
2 years ago

What's your thoughts 0n MBRX?

0
Reply
LIVE
Visit Money Morning Live


Latest News

January 19, 2023 • By Money Morning Stock Research Team

These Stocks Could Go To $0

January 9, 2023 • By Money Morning Stock Research Team

The Government Is Pouring $391 Billion Into These Stocks - Buy Now

December 27, 2022 • By Money Morning Staff Reports

6 IPOs in 2023 You Can’t Afford to Miss
Trending Stories
ABOUT MONEY MORNING

Money Morning gives you access to a team of market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.

QUICK LINKS
About Us COVID-19 Announcements How Money Morning Works FAQs Contact Us Search Article Archive Forgot Username/Password Archives Profit Academy Research Your Team Videos Text Messaging Terms of Use
FREE NEWSLETTERS
Total Wealth Research Power Profit Trades Profit Takeover This Is VWAP Penny Hawk Trading Today Midday Momentum Pump Up the Close
PREMIUM SERVICES
Money Map Press Home Money Map Report Fast Fortune Club Weekly Cash Clock Night Trader Microcurrency Trader Hyperdrive Portfolio Rocket Wealth Initiative Extreme Profit Hunters Profit Revolution Warlock's World Penny Nation Quantum Data Profits Live Trading Alliance Trade The Close Inside Money Trader Expiration Trader Vega Burst Trader Flashpoint Trader Darknet Hyper Momentum Trader

Ā© 2023 Money Morning All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning.

Address: 1125 N Charles St. | Baltimore, MD, 21201 | USA | Phone: 888.384.8339 | Disclaimer | Sitemap | Privacy Policy | Whitelist Us | Do Not Sell My Info

wpDiscuz